Pharma IQ Members


Jonas Boström

Jonas Boström is a drug hunter, more specifically a computational medicinal chemist, working at AstraZeneca, Mölndal, Sweden. Jonas has gained knowledge of most aspects of preclinical drug discovery from his 15 years in the pharmaceutical industry. Among other things, this has resulted in 15 patent specifications, including 10 candidate drugs, one which is currently in clinical phase-III studies, looking very promising. Current research interest includes combining informatics and science in innovative ways to tackle the challenging tasks in drug discovery.

See linkedin profile for more info:öm/4/405/43a

Jonas Boström, of AstraZeneca explains how the idea of drug-likeness rules has been controversial ever since Lipinski introduced his rule of five for predicting oral bioavailability 15 years ago....Full Article »